NP48925a Hereditary Angioedema Branded Medicines (Orladeyo)
Supply of Hereditary Angioedema Branded Medicines to NHS Scotland: NP48925a Hereditary Angioedema Branded Medicines (Orladeyo®)
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£1,582,400
Published
13 May 2025
Closes
13 May 2025
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 NP48925a Hereditary Angioedema Branded Medicines (Orladeyo)
£1,582,400
The Framework Agreement is for the supply of berotralstat 150mg capsules (Orladeyo) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Delivery: Scotland
Documents
Unlock document linkNP48925a Hereditary Angioedema Branded Medicines (Orladeyo)
Not provided
Supply of Hereditary Angioedema Branded Medicines to NHS Scotland: NP48925a Hereditary Angioedema Branded Medicines (Orladeyo®)
Award notice · Web page
NP48925a Hereditary Angioedema Branded Medicines (Orladeyo)
Not provided
Supply of Hereditary Angioedema Branded Medicines to NHS Scotland: NP48925a Hereditary Angioedema Branded Medicines (Orladeyo®)
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.